Show simple item record

dc.contributor.authorEeles, R
dc.date.accessioned2019-09-20T10:03:55Z
dc.date.issued2019-09-17
dc.identifier.citationEuropean Urology, 2019
dc.identifier.issn0302-2838
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3359
dc.languageeng
dc.language.isoeng
dc.publisherElsevier
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleInterim Results from the IMPACT Study: Evidence for prostate specific antigen screening in BRCA2 mutation Carriers
dc.typeJournal Article
dcterms.dateAccepted2019-08-29
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2019-09-17
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean Urology
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.publication-statusPublished
pubs.embargo.termsNo embargo
icr.researchteamOncogeneticsen_US
dc.contributor.icrauthorEeles, Rosalinden


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0